In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

The free consultation period for this content is over.

It is now only available year-round to EAPC Ivory (& above) Members, Fellows of the ESC and Young combined Members

Evaluation of the efficacy of cardiovascular prevention in the framework of the World Heart Day

Session Poster Session III - Friday 08:30 - 12:30

Speaker Nana Goar Pogosova

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2015

  • Topic : e-cardiology / digital health, public health, health economics, research methodology
  • Sub-topic : Public Health and Health Economics
  • Session type : Poster Session

Authors : N Pogosova (Moscow,RU), A Evdokimova (Moscow,RU), A Ausheva (Moscow,RU)

Authors:
N Pogosova1 , A Evdokimova1 , A Ausheva1 , 1National Center for Preventive Medicine - Moscow - Russian Federation ,

Citation:

On the eve of World Heart Day, which is held annually around the world on September 29 at the initiative of the World Heart Federation, a number of activities were organized on September 22-29, 2014 in the state medical organizations of the public healthcare system by the Ministry of Healthcare of the Moscow city (currently more than 12 million people live in Moscow according to the official data). The aim of these activities was to attract attention of inhabitants to modern possibilities of prevention of cardiovascular diseases (CVD), risk factors and CVD complications, importance of timely referral, and new approaches in treatment of CVD.

As a part of these activities a campaign «Is your patient’s cholesterol level optimal?" has been held.  In the frame of this campaign patients of the public healthcare system of the Moscow city, who have passed health-checks in the first quarter of 2014, were invited to out-patient clinics for re-examination of total cholesterol. The aim was to assess the effectiveness of a previously recommended lifestyle changes and/or lipid-lowering medications.

2392 patients participated in the campaign, of this 835 patients (during health-checks in the first quarter of 2014) were diagnosed to have coronary heart disease and 1557 patients - high CVD risk (>5% risk according to the high-risk countries SCORE scale). More than half of patients reported that they followed a low-fat diet, up to 16% noted that they had increased their physical activity, although less than 1.5% gave up smoking. Every third patient without coronary heart disease has been recommended statins. Special attention was paid to the minority of patients with slight negative (11%) or without dynamics (7%) of total cholesterol.  In most patients was found an improvement of cholesterol level. The results served as the basis of analysis of clinical cases without positive cholesterol dynamics in preventive departments.

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are